Adjuvant Radiation in Aortic Valvuloplasty - ARAVA
Primary Purpose
Aortic Valve Stenosis
Status
Terminated
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Balloon Aortic Valvuloplasty
External Beam Radiation
Sponsored by
About this trial
This is an interventional treatment trial for Aortic Valve Stenosis
Eligibility Criteria
Inclusion Criteria: Severe Aortic Stenosis NYHA Class 2-4 CHF Symptoms Age > 75 EuroSCORE > 7 Prohibitively High Risk for Aortic Valve Replacement Surgery as Designated by a Cardiac Surgeon
Sites / Locations
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00269165
First Posted
December 22, 2005
Last Updated
May 28, 2010
Sponsor
Medstar Health Research Institute
1. Study Identification
Unique Protocol Identification Number
NCT00269165
Brief Title
Adjuvant Radiation in Aortic Valvuloplasty - ARAVA
Study Type
Interventional
2. Study Status
Record Verification Date
May 2010
Overall Recruitment Status
Terminated
Study Start Date
November 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Medstar Health Research Institute
4. Oversight
5. Study Description
Brief Summary
This study will examine the effect of external beam radiation therapy in the prevention of restenosis following successful balloon aortic valvuloplasty in severe, symptomatic aortic stenosis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aortic Valve Stenosis
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
60 (false)
8. Arms, Groups, and Interventions
Intervention Type
Procedure
Intervention Name(s)
Balloon Aortic Valvuloplasty
Intervention Type
Procedure
Intervention Name(s)
External Beam Radiation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Severe Aortic Stenosis
NYHA Class 2-4 CHF Symptoms
Age > 75
EuroSCORE > 7
Prohibitively High Risk for Aortic Valve Replacement Surgery as Designated by a Cardiac Surgeon
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ron Waksman, MD
Organizational Affiliation
Medstar Health Research Institute
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Adjuvant Radiation in Aortic Valvuloplasty - ARAVA
We'll reach out to this number within 24 hrs